Comparison of Xelox with Folfox Chemotherapy in Patients with Non-Metastatic Colon Cancer
Phase 2
Recruiting
- Conditions
- colorectal cancer.Malignant neoplasm of colon
- Registration Number
- IRCT20210913052454N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Platelet = 100000
White blood cell WBC = 3000 - hemoglobin = 10
Serum creatinine = 1.5 times the maximum normal level
Exclusion Criteria
Pregnancy, breastfeeding
Inability to swallow
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ocal recurrence. Timepoint: One year period. Method of measurement: Colonoscopy.;Distant metastasis. Timepoint: One year period. Method of measurement: Tumor marker and CT scan.
- Secondary Outcome Measures
Name Time Method Patient survival. Timepoint: 2 years. Method of measurement: Follow up patients.